Risk assessment criteria | n | % |
---|---|---|
Mobility | ||
Significantly reduced mobility | 593 | 58.7 |
Thrombosis risk (based on 593 patients with reduced mobility) | ||
Active cancer or cancer treatment | 69 | 11.6 |
Age >60 years | 587 | 99.0 |
Dehydration | NM | NM |
Known thrombophilias | 2 | 0.3 |
Obesity (BMI >30 kg/m2) | 83 | 14.0 |
One or more significant medical comorbiditiesa | 425 | 71.7 |
Personal history of VTE | 60 | 10.1 |
Use of hormone replacement therapy | 1 | 0.2 |
Use of oestrogen-containing contraceptive therapy | 0 | 0.0 |
Varicose veins with phlebitis | 2 | 0.3 |
Pregnancy or <6 weeks postpartum | 0 | 0.0 |
Number with at least one thrombosis risk factor | 593 | 100% |
↵a Heart disease; metabolic, endocrine, or respiratory pathologies; acute infectious diseases; inflammatory conditions. BMI = body mass index. NM = not measured. VTE = venous thromboembolism.